Interactions in solution between cyclodextrins and statins;Ciklodextrinek és sztatinok kölcsönhatásának in vitro vizsgálatai

Acta Pharmaceutica Hungarica

Volumn 75, Issue 4, 2005, Pages 179-183

  Süle, András ^a   Szente, Lajos ^b   Csempesz, Ferenc ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; MEVINOLIN; OLIGOSACCHARIDE; SIMVASTATIN; STATINE DERIVATIVE; CYCLODEXTRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; PH; TEMPERATURE DEPENDENCE; CHEMICAL STRUCTURE; CHEMISTRY; SOLUBILITY; SOLUTION AND SOLUBILITY;

CYCLODEXTRINS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SIMVASTATIN; SOLUBILITY; SOLUTIONS;

EID: 29944446424     PISSN: 00016659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Davis, M. E., Brewster, M. E.: Cyclodextrin-based Pharmaceutics: Past, Present and Future. Nature Reviews Drug Discovery 3, 1023-1035 (2004)
2. Szejtli, J., Sebestyén, Gy.: Starch 31, 385-386 (1979)
3. Szejtli, J.: Cyclodextrins and Their Inclusion Complexes, Akadémiai Kiadó, Budapest (1982)
4. Bergeron, R. J.: Inclusion compounds, Academic Press, London, 1984. 3. kötet 391
5. Liu, S., Guo, Q.X.: The Driving Forces in the Inclusion Complexation of Cyclodextrins, Journal of Inclusion Phenomena and Macrocyclic Chemistry 42, 1-14 (2002)
6. Fürst, Zs.(szerk): Farmakológia, Medicina Könyvkiadó, Budapest, 2001
7. Bailey, D. G.: Compendium of Pharmaceuticals and Specialities, Canadian Pharmacist Association, 2002 88
8. Higuchi, T., Connors, K. A.: Phase-Solubility Techniques, Advances in Analytical Chemistry and Instrumentation 4, 117 (1965)
9. Süle, A., Csempesz, F.: Hatóanyag-oldékonyság szabályozása ciklodextrinekkel és kolloidokkal. Semmelweis Egyetem PhD Tudományos Napok, Budapest, 2005
10. Hamelin, B. A., Turgeon, J.: Hydrophilicty/lipophilicity: relevance for the pharma-cology and clinical effects of HMG-CoA reductase inhibitors, Trends in Pharmacological Sciences 19, 26 (1998)
11. Süle, A., Szente, L., Csempesz, F.: Sztatinok kölcsö nhatása ciklodextrinekkel és makromolekulákkal. Farmakokinetika és Gyógyszermetabolizmus Szimpozium, Mátraháza, 2004.